Safety and efficacy of peptide receptor radionuclide therapy in neuroendocrine tumors: A single center experience von Sukrithan, Vineeth, Armbruster, Heather, Rogers, Sherise, Vogt, Sherry Mori, Grenade, Cassandra, Verschraegen, Claire, Zhou, Ye, Goyal, Ashima, Natwa, Mona, Hussein, Akram, Barr, Hallie, Konate, Dramane, Batdorf, Rochelle, Brown, Andrew, Williams, Bonnie, Zhao, Songzhu, Wei, Lai, Xu, Menglin, Shah, Manisha H, Konda, Bhavana

Volltext

First real-world experience of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors (NET) since US FDA approval von Konda, Bhavana, Rogers, Sherise C., Grenade, Cassandra Natalie, Verschraegen, Claire F., Zhou, Ye, Goyal, Ashima, Natwa, Mona, Wright, Chadwick, Hussein, Akram, Barr, Hallie, Konate, Dramane, Brown, Andrew, Batdorf, Rochelle, Williams, Bonnie, Zhao, Songzhu, Wei, Lai, Shah, Manisha H.

Volltext

Safety and efficacy of peptide receptor radionuclide therapy in neuroendocrine tumors: A single center experience von Vineeth Sukrithan, Heather Armbruster, Sherise Rogers, Sherry Mori Vogt, Cassandra Grenade, Claire Verschraegen, Ye Zhou, Ashima Goyal, Mona Natwa, Akram Hussein, Hallie Barr, Dramane Konate, Rochelle Batdorf, Andrew Brown, Bonnie Williams, Songzhu Zhao, Lai Wei, Menglin Xu, Manisha H. Shah, Bhavana Konda

Volltext